Doctor of Podiatric Medicine Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Liset Perez

Podiatrist Miami, FL Doctor of Podiatric Medicine

NPI 1063280469 CMS profile 11531358

320 Nw 115Th St, Miami, FL 33168

Open in the dashboard

General payments

$5,484

64 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Liset Perez of Miami, FL is reported in the CMS Open Payments database as having received $5,484 across 64 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,629 26
2024 General $3,650 37
2023 General $205 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Liset Perez
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Liset Perez were reported at $1,629. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Liset Perez Podiatrist median Middle half National median
2019 $0 $196 $72–$601 $163
2020 $0 $118 $38–$335 $114
2021 $0 $169 $57–$573 $132
2022 $0 $220 $74–$782 $149
2023 $205 $208 $71–$635 $160
2024 $3,650 $237 $87–$681 $164
2025 $1,629 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Stryker Corporation $2,180 26 payments
  2. TissueTech, Inc. $1,092 9 payments
  3. Aroa Biosurgery Incorporated $457 7 payments
  4. Kerecis Limited $286 2 payments
  5. ConvaTec Inc. $248 4 payments
  6. Innovation Technologies Inc $233 2 payments
  7. Organogenesis Inc. $228 2 payments
  8. Sanara MedTech Inc. $203 1 payment
  9. PolyNovo North America LLC $180 3 payments
  10. Averitas Pharma Inc. $122 1 payment
  11. Other $255 7 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $4,227 60 payments
  2. Travel and Lodging $1,258 4 payments
Products named General payments · program years 2023–2025
  1. SALVATION $837 13 payments
  2. HOFFMANN $601 1 payment
  3. Kerecis Omega3 SurgiClose $286 2 payments
  4. ORTHOLOC 3DI $263 5 payments
  5. CLARIX $250 2 payments
  6. INNOVAMATRIX AC $248 4 payments
  7. Irrisept $233 2 payments
  8. PURAPLY WOUND MATRIX $228 2 payments
  9. PROSTEP MICA $211 2 payments
  10. Kerecis Omega3 GraftGuide $205 1 payment
  11. Other $2,494 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

64 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record